| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Shijiazhuang Yiling Pharmaceutical Co. Ltd (SHE: 002603)
002603 Technical Analysis
5
| As on 17th Nov 2025 002603 STOCK Price closed @ 19.91 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 15.84 & Strong Buy for SHORT-TERM with Stoploss of 16.60 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002603STOCK Price
| Open | 21.06 | Change | Price | % |
| High | 21.10 | 1 Day | -1.14 | -5.42 |
| Low | 19.81 | 1 Week | 2.39 | 13.64 |
| Close | 19.91 | 1 Month | 4.10 | 25.93 |
| Volume | 71980820 | 1 Year | 0.50 | 2.58 |
| 52 Week High 20.47 | 52 Week Low 12.84 | ||||
SHE China Most Active Stocks
| 300058 | 8.69 | 12.42% |
| 000564 | 2.84 | 1.07% |
| 000981 | 3.53 | 0.57% |
| 002506 | 3.14 | -2.48% |
| 000620 | 3.83 | 10.06% |
| 000572 | 10.94 | 0.00% |
| 002426 | 4.06 | 7.41% |
| 002146 | 1.88 | -3.59% |
| 002131 | 5.09 | 4.73% |
| 000725 | 3.96 | -1.00% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 002603 Daily Charts |
002603 Intraday Charts |
Whats New @ Bazaartrend |
002603 Free Analysis |
|
|
002603 Important Levels Intraday
| RESISTANCE | 22.40 |
| RESISTANCE | 21.60 |
| RESISTANCE | 21.11 |
| RESISTANCE | 20.61 |
| SUPPORT | 19.21 |
| SUPPORT | 18.71 |
| SUPPORT | 18.22 |
| SUPPORT | 17.42 |
002603 Forecast November 2025
| 4th UP Forecast | 26.44 |
| 3rd UP Forecast | 24.35 |
| 2nd UP Forecast | 23.05 |
| 1st UP Forecast | 21.76 |
| 1st DOWN Forecast | 18.06 |
| 2nd DOWN Forecast | 16.77 |
| 3rd DOWN Forecast | 15.47 |
| 4th DOWN Forecast | 13.38 |
002603 Weekly Forecast
| 4th UP Forecast | 22.47 |
| 3rd UP Forecast | 21.65 |
| 2nd UP Forecast | 21.14 |
| 1st UP Forecast | 20.63 |
| 1st DOWN Forecast | 19.19 |
| 2nd DOWN Forecast | 18.68 |
| 3rd DOWN Forecast | 18.17 |
| 4th DOWN Forecast | 17.35 |
002603 Forecast2025
| 4th UP Forecast | 37.58 |
| 3rd UP Forecast | 31.91 |
| 2nd UP Forecast | 28.41 |
| 1st UP Forecast | 24.91 |
| 1st DOWN Forecast | 14.91 |
| 2nd DOWN Forecast | 11.41 |
| 3rd DOWN Forecast | 7.91 |
| 4th DOWN Forecast | 2.24 |
Shijiazhuang Yiling Pharmaceutical Co. Ltd ( SHE China Symbol : 002603 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002603 Business Profile
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others. The company sells its products through physical display and online. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China. Address: No. 238 Tianshan Street, Shijiazhuang, China, 050035
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service